CIO

The ‘Genesis’ gamble: Creating order from chaos in the age of AI

Your board doesn’t want chatbots — they want growth. AI is a high-stakes bet on productivity, and playing small is the real risk.

The UAE is testing the use of lasers to stimulate rainfall

Discover how the UAE is pioneering laser technology to enhance rainfall, marking a breakthrough in sustainable water management. This innovative project, led by the Technology Innovation Institute, ...

Opinion | What ChatGPT is now doing with your darkest secrets

For over three years now, millions across the world have treated ChatGPT like a confidante. And one company - OpenAI - holds ...

FDA approves RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) as the only EGFR-targeted therapy that can be administered once a month

Johnson & Johnson (NYSE: JNJ) today announced the U.S. Food and Drug Administration (FDA) has approved a new, simplified monthly dosing schedule* for RYBREVANT FASPRO™ (amivantamab and ...

Johnson & Johnson: FDA approves RYBREVANT FASPRO (amivantamab and hyaluronidase-lpuj) as the only EGFR-targeted therapy that can be administered once a month

Monthly dosing reduces treatment visits while maintaining established safety and efficacy1,2 Builds on RYBREVANT FASPRO FDA approval to deliver the simplest and fastest ...
Common DreamsOpinion

Creative Dissent and Mutual Aid: Lessons From Minneapolis for Surviving the Polycrisis

As the Trump regime promises to end its surge of federal agents in that city, perhaps it’s a good time to reflect: What have ...
The McGill Daily

Better in Print

Performance cookies are used to understand and analyse the key performance indexes of the website which helps in delivering a better user experience for the visitors.